1. |
Zhou YM, Yin ZF, Yang JM, et al. Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. World J Gastroen-terol, 2008, 14(4): 632-635.
|
2. |
Casavilla FA, Marsh JW, Iwatsuki S, et al. Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg, 1997, 185(5): 429-436.
|
3. |
Poultsides GA, Zhu AX, Choti MA, et al. Intrahepatic cholangiocar-cinoma. J Surg Clin North Am, 2010, 90(4): 817-837.
|
4. |
Witjes CD, Karim-Kos HE, Visser O, et al. Intrahepatic cholangio-carcinoma in a low endemic area: rising incidence and improved survival. HPB (Oxford), 2012, 14 (11): 777-781.
|
5. |
Lim JH. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol, 2003, 181(3): 819-827.
|
6. |
Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepa-tology, 2011, 54(1): 173-184.
|
7. |
Palmer WC, Patel T. Are common factors involved in the pathogen-esis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol, 2012, 57(1): 69-76.
|
8. |
袁磊, 罗贤武, 王义.肝内胆管细胞癌发病机制研究进展.肝胆外科杂志, 2013, 21(5): 389-391.
|
9. |
Fava G, Marzioni M, Benedetti A, et al. Molecular pathology of biliary tract cancers. Cancer Lett, 2007, 250(2): 155-167.
|
10. |
Ben-Menachem T. Risk factors for cholangiocarcinoma. Eur J Gastroenterol Hepatol, 2007, 19(8): 615-617.
|
11. |
Mosconi S, Beretta GD, Labianca R, et al. Cholangiocarcinoma. Crit Rev Oncol Hematol, 2009, 69(3): 259-270.
|
12. |
Welzel TM, Graubard BI, El-Serag HB, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol, 2007, 5(10): 1221-1228.
|
13. |
Kobayashi M, Ikeda K, Saitoh S, et al. Incidence of primary cholan-giocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis. Cancer, 2000, 88(11): 2471-2477.
|
14. |
Shaib YH, El-Serag HB, Davila JA, et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology, 2005, 128(3): 620-626.
|
15. |
Liang X, Bi S, Yang W, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis, 2009, 200(1): 39-47.
|
16. |
Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccina-tion. Vaccine, 2009, 27(47): 6550-6557.
|
17. |
路利军, 李鹏, 雷小艳, 等.肝内胆管细胞癌的螺旋CT诊断.中国临床研究, 2011, 24(9): 818-819.
|
18. |
Olnes MJ, Erlich R. A review and update on cholangiocarcinoma. Oncology, 2004, 66(3): 167-179.
|
19. |
Nehls O, Gregor M, Klump B. Serum and bile markers for cholang-iocarcinoma. Semin Liver Dis, 2004, 24(2): 139-154.
|
20. |
Kalambokis G, Kostoula A, Economou M, et al. Tumor necrosis factor-alpha-related intraperitoneal release of CA 125 in cirrhotic patients with sterile ascites. Clin Chem, 2005, 51(11): 2207-2208.
|
21. |
肖文斌, 刘玉兰.肝硬化患者血清和腹水CA125升高.世界华人消化杂志, 2003, 11(11): 1720-1722.
|
22. |
何振平, 马宽生, 王曙光, 等.肝内胆管癌的临床病理特征与外科治疗.中华肝胆外科杂志, 2002, 8(8): 475-477.
|
23. |
Peng NF, Li LQ, Qin X, et al. Evaluation of risk factors and clinico-pathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of hepatitis B virus. Ann Surg Oncol, 2011, 18(5): 1258-1266.
|
24. |
Yu TH, Yuan RH, Chen YL, et al. Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression. Mod Pathol, 2011, 24(6): 810-819.
|
25. |
Ishikawa K, Sasaki A, Haraguchi N, et al. A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin. Oncologist, 2007, 12(3): 320-324.
|
26. |
郭琪, 袁知东.肝内胆管细胞癌的MSCT诊断价值.中国CT和MRI杂志, 2010, 8(2): 25-27.
|
27. |
Maetani Y, Itoh K, Watanabe C, et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roent-genol, 2001, 176(6): 1499-1507.
|